IGF-1 LR3 — laboratory reference
When qualified laboratories evaluate UK peptides for B2B supply, documentation scope matters as much as catalogue identity: COA and SDS ship with released lots, and third-party testing is included only when explicitly released for that batch.
IGF-1 LR3 is supplied as lyophilised laboratory reference material for qualified in-vitro and analytical research with batch documentation.
Key facts
- SKU: ALP-IGF
- Form: Lyophilised powder
- Presentation: Mass per vial as selected on the product page
- Appearance (typical): White to off-white lyophilised powder
Intended laboratory context
- Controlled in-vitro models where IGF-axis biology is studied under institutional protocols
- Analytical characterisation and method development
- Non-clinical peptide handling and preparation workflows in laboratory settings
Specifications
- Batch identity and purity parameters appear on the COA where stated for the lot supplied
- Handle as potent laboratory peptide per SDS
- Documentation scope may be limited to in-house or supplier release records for some lots (see notice in short description)
Documentation and batch release
COA and SDS are supplied with released lots within the scope described on this page. Independent third-party reports are provided only when released for a specific lot.
Storage and handling
- Store lyophilised material frozen (typically -20 °C) unless SDS states otherwise
- Protect from moisture and light; minimise freeze–thaw cycles
Solubility and reconstitution
Follow SDS and SOP. Laboratory-grade sterile or bacteriostatic water may be used where appropriate for documented preparation steps.
Related materials
Bacteriostatic water for laboratory preparation | Long R3 laboratory reference
FAQs
What documentation ships with orders?
COA and SDS for released lots, within the analytical scope described on this page.
Is third-party testing on every batch?
No. Some lots ship with in-house or supplier release records only; third-party reports when released for that lot.
Who is supply intended for?
Qualified UK laboratories and research organisations.
How should storage be managed after reconstitution?
Follow your SOP and the SDS for stability, container choice, and holding time.
For qualified laboratory and in-vitro use only. Sold as non-clinical reference material; purchasers are responsible for lawful use, handling, and disposal per the SDS and applicable requirements.
